Market Analysis and Insights: Global and United States Fluoxetine Hydrochloride (Prozac) Market
This report focuses on global and United States Fluoxetine Hydrochloride (Prozac) market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Fluoxetine Hydrochloride (Prozac) market size is estimated to be worth US$ million in 2025 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Tablets accounting for % of the Fluoxetine Hydrochloride (Prozac) global market in 2025, is projected to value US$ million by 2031, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Depression was the leading segment, accounting for over percent market share in 2025, and altered to an % CAGR throughout this forecast period.
In United States the Fluoxetine Hydrochloride (Prozac) market size is expected to grow from US$ million in 2025 to US$ million by 2031, at a CAGR of % during the forecast period.
Global Fluoxetine Hydrochloride (Prozac) Scope and Market Size
Fluoxetine Hydrochloride (Prozac) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Fluoxetine Hydrochloride (Prozac) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2025-2031.
For United States market, this report focuses on the Fluoxetine Hydrochloride (Prozac) market size by players, by Type and by Application, for the period 2025-2031. The key players include the global and local players, which play important roles in United States.
Segment by Type
Tablets
Capsules
Segment by Application
Depression
Obsessive-Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
1 Study Coverage
1.1 Fluoxetine Hydrochloride (Prozac) Product Introduction
1.2 Global Fluoxetine Hydrochloride (Prozac) Outlook 2021 VS 2025 VS 2031
1.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales in US$ Million for the Year 2025-2031
1.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales in Volume for the Year 2025-2031
1.3 United States Fluoxetine Hydrochloride (Prozac) Outlook 2021 VS 2025 VS 2031
1.3.1 United States Fluoxetine Hydrochloride (Prozac) Sales in US$ Million for the Year 2025-2031
1.3.2 United States Fluoxetine Hydrochloride (Prozac) Sales in Volume for the Year 2025-2031
1.4 Fluoxetine Hydrochloride (Prozac) Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.4.1 The Market Share of United States Fluoxetine Hydrochloride (Prozac) in Global, 2021 VS 2025 VS 2031
1.4.2 The Growth Rate of Fluoxetine Hydrochloride (Prozac) Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.5 Fluoxetine Hydrochloride (Prozac) Market Dynamics
1.5.1 Fluoxetine Hydrochloride (Prozac) Industry Trends
1.5.2 Fluoxetine Hydrochloride (Prozac) Market Drivers
1.5.3 Fluoxetine Hydrochloride (Prozac) Market Challenges
1.5.4 Fluoxetine Hydrochloride (Prozac) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Fluoxetine Hydrochloride (Prozac) Market Segment by Type
2.1.1 Tablets
2.1.2 Capsules
2.2 Global Fluoxetine Hydrochloride (Prozac) Market Size by Type
2.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales in Value, by Type (2021, 2025 & 2031)
2.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales in Volume, by Type (2021, 2025 & 2031)
2.2.3 Global Fluoxetine Hydrochloride (Prozac) Average Selling Price (ASP) by Type (2021, 2025 & 2031)
2.3 United States Fluoxetine Hydrochloride (Prozac) Market Size by Type
2.3.1 United States Fluoxetine Hydrochloride (Prozac) Sales in Value, by Type (2021, 2025 & 2031)
2.3.2 United States Fluoxetine Hydrochloride (Prozac) Sales in Volume, by Type (2021, 2025 & 2031)
2.3.3 United States Fluoxetine Hydrochloride (Prozac) Average Selling Price (ASP) by Type (2021, 2025 & 2031)
3 Market by Application
3.1 Fluoxetine Hydrochloride (Prozac) Market Segment by Application
3.1.1 Depression
3.1.2 Obsessive-Compulsive Disorder
3.1.3 Panic Disorder
3.1.4 Bulimia Nervosa
3.1.5 Others
3.2 Global Fluoxetine Hydrochloride (Prozac) Market Size by Application
3.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales in Value, by Application (2021, 2025 & 2031)
3.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 Global Fluoxetine Hydrochloride (Prozac) Average Selling Price (ASP) by Application (2021, 2025 & 2031)
3.3 United States Fluoxetine Hydrochloride (Prozac) Market Size by Application
3.3.1 United States Fluoxetine Hydrochloride (Prozac) Sales in Value, by Application (2021, 2025 & 2031)
3.3.2 United States Fluoxetine Hydrochloride (Prozac) Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 United States Fluoxetine Hydrochloride (Prozac) Average Selling Price (ASP) by Application (2021, 2025 & 2031)
4 Global Fluoxetine Hydrochloride (Prozac) Competitor Landscape by Company
4.1 Global Fluoxetine Hydrochloride (Prozac) Market Size by Company
4.1.1 Top Global Fluoxetine Hydrochloride (Prozac) Manufacturers Ranked by Revenue (2025)
4.1.2 Global Fluoxetine Hydrochloride (Prozac) Revenue by Manufacturer (2021-2025)
4.1.3 Global Fluoxetine Hydrochloride (Prozac) Sales by Manufacturer (2021-2025)
4.1.4 Global Fluoxetine Hydrochloride (Prozac) Price by Manufacturer (2021-2025)
4.2 Global Fluoxetine Hydrochloride (Prozac) Concentration Ratio (CR)
4.2.1 Fluoxetine Hydrochloride (Prozac) Market Concentration Ratio (CR) (2021-2025)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Fluoxetine Hydrochloride (Prozac) in 2021
4.2.3 Global Fluoxetine Hydrochloride (Prozac) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Fluoxetine Hydrochloride (Prozac) Manufacturing Base Distribution, Product Type
4.3.1 Global Fluoxetine Hydrochloride (Prozac) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Fluoxetine Hydrochloride (Prozac) Product Type
4.3.3 Date of International Manufacturers Enter into Fluoxetine Hydrochloride (Prozac) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Fluoxetine Hydrochloride (Prozac) Market Size by Company
4.5.1 Top Fluoxetine Hydrochloride (Prozac) Players in United States, Ranked by Revenue (2025)
4.5.2 United States Fluoxetine Hydrochloride (Prozac) Revenue by Players (2023, 2024 & 2025)
4.5.3 United States Fluoxetine Hydrochloride (Prozac) Sales by Players (2023, 2024 & 2025)
5 Global Fluoxetine Hydrochloride (Prozac) Market Size by Region
5.1 Global Fluoxetine Hydrochloride (Prozac) Market Size by Region: 2021 VS 2025 VS 2031
5.2 Global Fluoxetine Hydrochloride (Prozac) Market Size in Volume by Region (2025-2031)
5.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales in Volume by Region: 2021-2025
5.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales in Volume Forecast by Region (2025-2031)
5.3 Global Fluoxetine Hydrochloride (Prozac) Market Size in Value by Region (2025-2031)
5.3.1 Global Fluoxetine Hydrochloride (Prozac) Sales in Value by Region: 2021-2025
5.3.2 Global Fluoxetine Hydrochloride (Prozac) Sales in Value by Region: 2025-2031
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Fluoxetine Hydrochloride (Prozac) Market Size YoY Growth 2025-2031
6.1.2 North America Fluoxetine Hydrochloride (Prozac) Market Facts & Figures by Country (2021, 2025 & 2031)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Fluoxetine Hydrochloride (Prozac) Market Size YoY Growth 2025-2031
6.2.2 Asia-Pacific Fluoxetine Hydrochloride (Prozac) Market Facts & Figures by Region (2021, 2025 & 2031)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Fluoxetine Hydrochloride (Prozac) Market Size YoY Growth 2025-2031
6.3.2 Europe Fluoxetine Hydrochloride (Prozac) Market Facts & Figures by Country (2021, 2025 & 2031)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Fluoxetine Hydrochloride (Prozac) Market Size YoY Growth 2025-2031
6.4.2 Latin America Fluoxetine Hydrochloride (Prozac) Market Facts & Figures by Country (2021, 2025 & 2031)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Fluoxetine Hydrochloride (Prozac) Market Size YoY Growth 2025-2031
6.5.2 Middle East and Africa Fluoxetine Hydrochloride (Prozac) Market Facts & Figures by Country (2021, 2025 & 2031)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Teva
7.1.1 Teva Corporation Information
7.1.2 Teva Description and Business Overview
7.1.3 Teva Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.1.4 Teva Fluoxetine Hydrochloride (Prozac) Products Offered
7.1.5 Teva Recent Development
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Corporation Information
7.2.2 Sun Pharmaceutical Description and Business Overview
7.2.3 Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.2.4 Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Products Offered
7.2.5 Sun Pharmaceutical Recent Development
7.3 Sandoz
7.3.1 Sandoz Corporation Information
7.3.2 Sandoz Description and Business Overview
7.3.3 Sandoz Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.3.4 Sandoz Fluoxetine Hydrochloride (Prozac) Products Offered
7.3.5 Sandoz Recent Development
7.4 Mylan
7.4.1 Mylan Corporation Information
7.4.2 Mylan Description and Business Overview
7.4.3 Mylan Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.4.4 Mylan Fluoxetine Hydrochloride (Prozac) Products Offered
7.4.5 Mylan Recent Development
7.5 Wockhardt
7.5.1 Wockhardt Corporation Information
7.5.2 Wockhardt Description and Business Overview
7.5.3 Wockhardt Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.5.4 Wockhardt Fluoxetine Hydrochloride (Prozac) Products Offered
7.5.5 Wockhardt Recent Development
7.6 Dr.Reddy's Laboratories
7.6.1 Dr.Reddy's Laboratories Corporation Information
7.6.2 Dr.Reddy's Laboratories Description and Business Overview
7.6.3 Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.6.4 Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Products Offered
7.6.5 Dr.Reddy's Laboratories Recent Development
7.7 Pharmaceutical Associates Inc.
7.7.1 Pharmaceutical Associates Inc. Corporation Information
7.7.2 Pharmaceutical Associates Inc. Description and Business Overview
7.7.3 Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.7.4 Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Products Offered
7.7.5 Pharmaceutical Associates Inc. Recent Development
7.8 Lannett Company
7.8.1 Lannett Company Corporation Information
7.8.2 Lannett Company Description and Business Overview
7.8.3 Lannett Company Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.8.4 Lannett Company Fluoxetine Hydrochloride (Prozac) Products Offered
7.8.5 Lannett Company Recent Development
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Corporation Information
7.9.2 Aurobindo Pharma Description and Business Overview
7.9.3 Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.9.4 Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Products Offered
7.9.5 Aurobindo Pharma Recent Development
7.10 Alembic Pharmaceuticals
7.10.1 Alembic Pharmaceuticals Corporation Information
7.10.2 Alembic Pharmaceuticals Description and Business Overview
7.10.3 Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.10.4 Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Products Offered
7.10.5 Alembic Pharmaceuticals Recent Development
7.11 Alvogen
7.11.1 Alvogen Corporation Information
7.11.2 Alvogen Description and Business Overview
7.11.3 Alvogen Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.11.4 Alvogen Fluoxetine Hydrochloride (Prozac) Products Offered
7.11.5 Alvogen Recent Development
7.12 Torrent Pharmaceuticals
7.12.1 Torrent Pharmaceuticals Corporation Information
7.12.2 Torrent Pharmaceuticals Description and Business Overview
7.12.3 Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.12.4 Torrent Pharmaceuticals Products Offered
7.12.5 Torrent Pharmaceuticals Recent Development
7.13 Suzhou YUSHI Pharmaceutical
7.13.1 Suzhou YUSHI Pharmaceutical Corporation Information
7.13.2 Suzhou YUSHI Pharmaceutical Description and Business Overview
7.13.3 Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.13.4 Suzhou YUSHI Pharmaceutical Products Offered
7.13.5 Suzhou YUSHI Pharmaceutical Recent Development
7.14 Changzhou Siyao Pharmaceutical
7.14.1 Changzhou Siyao Pharmaceutical Corporation Information
7.14.2 Changzhou Siyao Pharmaceutical Description and Business Overview
7.14.3 Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Revenue and Gross Margin (2021-2025)
7.14.4 Changzhou Siyao Pharmaceutical Products Offered
7.14.5 Changzhou Siyao Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Fluoxetine Hydrochloride (Prozac) Industry Chain Analysis
8.2 Fluoxetine Hydrochloride (Prozac) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Fluoxetine Hydrochloride (Prozac) Distributors
8.3 Fluoxetine Hydrochloride (Prozac) Production Mode & Process
8.4 Fluoxetine Hydrochloride (Prozac) Sales and Marketing
8.4.1 Fluoxetine Hydrochloride (Prozac) Sales Channels
8.4.2 Fluoxetine Hydrochloride (Prozac) Distributors
8.5 Fluoxetine Hydrochloride (Prozac) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Fluoxetine Hydrochloride (Prozac) CAGR in Value, United States VS Global, 2021 VS 2025 VS 2031
Table 2. Fluoxetine Hydrochloride (Prozac) Market Trends
Table 3. Fluoxetine Hydrochloride (Prozac) Market Drivers
Table 4. Fluoxetine Hydrochloride (Prozac) Market Challenges
Table 5. Fluoxetine Hydrochloride (Prozac) Market Restraints
Table 6. Global Fluoxetine Hydrochloride (Prozac) Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 7. United States Fluoxetine Hydrochloride (Prozac) Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 8. Global Fluoxetine Hydrochloride (Prozac) Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 9. United States Fluoxetine Hydrochloride (Prozac) Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 10. Top Fluoxetine Hydrochloride (Prozac) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Fluoxetine Hydrochloride (Prozac) Revenue by Manufacturer, (US$ Million), 2021-2025
Table 12. Global Fluoxetine Hydrochloride (Prozac) Revenue Share by Manufacturer, 2021-2025
Table 13. Global Fluoxetine Hydrochloride (Prozac) Sales by Manufacturer, (K Units), 2021-2025
Table 14. Global Fluoxetine Hydrochloride (Prozac) Sales Share by Manufacturer, 2021-2025
Table 15. Global Fluoxetine Hydrochloride (Prozac) Price by Manufacturer (2021-2025) & (US$/Unit)
Table 16. Global Fluoxetine Hydrochloride (Prozac) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Fluoxetine Hydrochloride (Prozac) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluoxetine Hydrochloride (Prozac) as of 2021)
Table 18. Top Players of Fluoxetine Hydrochloride (Prozac) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Fluoxetine Hydrochloride (Prozac) Product Type
Table 20. Date of International Manufacturers Enter into Fluoxetine Hydrochloride (Prozac) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Fluoxetine Hydrochloride (Prozac) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Fluoxetine Hydrochloride (Prozac) Revenue by Players, (US$ Million), 2023, 2024 & 2025
Table 24. United States Fluoxetine Hydrochloride (Prozac) Revenue Share by Players, 2023, 2024 & 2025
Table 25. United States Fluoxetine Hydrochloride (Prozac) Sales by Players, (K Units), 2023, 2024 & 2025
Table 26. United States Fluoxetine Hydrochloride (Prozac) Sales Share by Players, 2023, 2024 & 2025
Table 27. Global Fluoxetine Hydrochloride (Prozac) Market Size by Region (US$ Million): 2021 VS 2025 VS 2031
Table 28. Global Fluoxetine Hydrochloride (Prozac) Sales in Volume by Region (2021-2025) & (K Units)
Table 29. Global Fluoxetine Hydrochloride (Prozac) Sales in Volume Forecast by Region (2025-2031) & (K Units)
Table 30. Global Fluoxetine Hydrochloride (Prozac) Sales in Value by Region (2021-2025) & (US$ Million)
Table 31. Global Fluoxetine Hydrochloride (Prozac) Sales in Value Forecast by Region (2025-2031) & (US$ Million)
Table 32. North America Fluoxetine Hydrochloride (Prozac) Sales in Volume by Country (2025-2031) & (K Units)
Table 33. North America Fluoxetine Hydrochloride (Prozac) Sales in Value by Country (2025-2031) & (US$ Million)
Table 34. Asia Pacific Fluoxetine Hydrochloride (Prozac) Sales in Volume by Region (2025-2031) & (K Units)
Table 35. Asia Pacific Fluoxetine Hydrochloride (Prozac) Sales in Value by Region (2025-2031) & (US$ Million)
Table 36. Europe Fluoxetine Hydrochloride (Prozac) Sales in Volume by Country (2025-2031) & (K Units)
Table 37. Europe Fluoxetine Hydrochloride (Prozac) Sales in Value by Country (2025-2031) & (US$ Million)
Table 38. Latin America Fluoxetine Hydrochloride (Prozac) Sales in Volume by Country (2025-2031) & (K Units)
Table 39. Latin Americaa Fluoxetine Hydrochloride (Prozac) Sales in Value by Country (2025-2031) & (US$ Million)
Table 40. Middle East and Africa Fluoxetine Hydrochloride (Prozac) Sales in Volume by Country (2025-2031) & (K Units)
Table 41. Middle East and Africa Fluoxetine Hydrochloride (Prozac) Sales in Value by Country (2025-2031) & (US$ Million)
Table 42. Teva Corporation Information
Table 43. Teva Description and Business Overview
Table 44. Teva Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 45. Teva Fluoxetine Hydrochloride (Prozac) Product
Table 46. Teva Recent Development
Table 47. Sun Pharmaceutical Corporation Information
Table 48. Sun Pharmaceutical Description and Business Overview
Table 49. Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 50. Sun Pharmaceutical Product
Table 51. Sun Pharmaceutical Recent Development
Table 52. Sandoz Corporation Information
Table 53. Sandoz Description and Business Overview
Table 54. Sandoz Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 55. Sandoz Product
Table 56. Sandoz Recent Development
Table 57. Mylan Corporation Information
Table 58. Mylan Description and Business Overview
Table 59. Mylan Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 60. Mylan Product
Table 61. Mylan Recent Development
Table 62. Wockhardt Corporation Information
Table 63. Wockhardt Description and Business Overview
Table 64. Wockhardt Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 65. Wockhardt Product
Table 66. Wockhardt Recent Development
Table 67. Dr.Reddy's Laboratories Corporation Information
Table 68. Dr.Reddy's Laboratories Description and Business Overview
Table 69. Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 70. Dr.Reddy's Laboratories Product
Table 71. Dr.Reddy's Laboratories Recent Development
Table 72. Pharmaceutical Associates Inc. Corporation Information
Table 73. Pharmaceutical Associates Inc. Description and Business Overview
Table 74. Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 75. Pharmaceutical Associates Inc. Product
Table 76. Pharmaceutical Associates Inc. Recent Development
Table 77. Lannett Company Corporation Information
Table 78. Lannett Company Description and Business Overview
Table 79. Lannett Company Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 80. Lannett Company Product
Table 81. Lannett Company Recent Development
Table 82. Aurobindo Pharma Corporation Information
Table 83. Aurobindo Pharma Description and Business Overview
Table 84. Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 85. Aurobindo Pharma Product
Table 86. Aurobindo Pharma Recent Development
Table 87. Alembic Pharmaceuticals Corporation Information
Table 88. Alembic Pharmaceuticals Description and Business Overview
Table 89. Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 90. Alembic Pharmaceuticals Product
Table 91. Alembic Pharmaceuticals Recent Development
Table 92. Alvogen Corporation Information
Table 93. Alvogen Description and Business Overview
Table 94. Alvogen Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 95. Alvogen Product
Table 96. Alvogen Recent Development
Table 97. Torrent Pharmaceuticals Corporation Information
Table 98. Torrent Pharmaceuticals Description and Business Overview
Table 99. Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 100. Torrent Pharmaceuticals Product
Table 101. Torrent Pharmaceuticals Recent Development
Table 102. Suzhou YUSHI Pharmaceutical Corporation Information
Table 103. Suzhou YUSHI Pharmaceutical Description and Business Overview
Table 104. Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 105. Suzhou YUSHI Pharmaceutical Product
Table 106. Suzhou YUSHI Pharmaceutical Recent Development
Table 107. Changzhou Siyao Pharmaceutical Corporation Information
Table 108. Changzhou Siyao Pharmaceutical Description and Business Overview
Table 109. Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 110. Changzhou Siyao Pharmaceutical Product
Table 111. Changzhou Siyao Pharmaceutical Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Fluoxetine Hydrochloride (Prozac) Customers List
Table 115. Fluoxetine Hydrochloride (Prozac) Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Fluoxetine Hydrochloride (Prozac) Product Picture
Figure 2. Global Fluoxetine Hydrochloride (Prozac) Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 3. Global Fluoxetine Hydrochloride (Prozac) Market Size 2025-2031 (US$ Million)
Figure 4. Global Fluoxetine Hydrochloride (Prozac) Sales 2025-2031 (K Units)
Figure 5. United States Fluoxetine Hydrochloride (Prozac) Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 6. United States Fluoxetine Hydrochloride (Prozac) Market Size 2025-2031 (US$ Million)
Figure 7. United States Fluoxetine Hydrochloride (Prozac) Sales 2025-2031 (K Units)
Figure 8. United States Fluoxetine Hydrochloride (Prozac) Market Share in Global, in Value (US$ Million) 2025-2031
Figure 9. United States Fluoxetine Hydrochloride (Prozac) Market Share in Global, in Volume (K Units) 2025-2031
Figure 10. Fluoxetine Hydrochloride (Prozac) Report Years Considered
Figure 11. Product Picture of Tablets
Figure 12. Product Picture of Capsules
Figure 13. Global Fluoxetine Hydrochloride (Prozac) Market Share by Type in 2025 & 2031
Figure 14. Global Fluoxetine Hydrochloride (Prozac) Sales in Value by Type (2025-2031) & (US$ Million)
Figure 15. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share in Value by Type (2025-2031)
Figure 16. Global Fluoxetine Hydrochloride (Prozac) Sales by Type (2025-2031) & (K Units)
Figure 17. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share in Volume by Type (2025-2031)
Figure 18. Global Fluoxetine Hydrochloride (Prozac) Price by Type (2025-2031) & (US$/Unit)
Figure 19. United States Fluoxetine Hydrochloride (Prozac) Market Share by Type in 2025 & 2031
Figure 20. United States Fluoxetine Hydrochloride (Prozac) Sales in Value by Type (2025-2031) & (US$ Million)
Figure 21. United States Fluoxetine Hydrochloride (Prozac) Sales Market Share in Value by Type (2025-2031)
Figure 22. United States Fluoxetine Hydrochloride (Prozac) Sales by Type (2025-2031) & (K Units)
Figure 23. United States Fluoxetine Hydrochloride (Prozac) Sales Market Share in Volume by Type (2025-2031)
Figure 24. United States Fluoxetine Hydrochloride (Prozac) Price by Type (2025-2031) & (US$/Unit)
Figure 25. Product Picture of Depression
Figure 26. Product Picture of Obsessive-Compulsive Disorder
Figure 27. Product Picture of Panic Disorder
Figure 28. Product Picture of Bulimia Nervosa
Figure 29. Product Picture of Others
Figure 30. Global Fluoxetine Hydrochloride (Prozac) Market Share by Application in 2025 & 2031
Figure 31. Global Fluoxetine Hydrochloride (Prozac) Sales in Value by Application (2025-2031) & (US$ Million)
Figure 32. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share in Value by Application (2025-2031)
Figure 33. Global Fluoxetine Hydrochloride (Prozac) Sales by Application (2025-2031) & (K Units)
Figure 34. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share in Volume by Application (2025-2031)
Figure 35. Global Fluoxetine Hydrochloride (Prozac) Price by Application (2025-2031) & (US$/Unit)
Figure 36. United States Fluoxetine Hydrochloride (Prozac) Market Share by Application in 2025 & 2031
Figure 37. United States Fluoxetine Hydrochloride (Prozac) Sales in Value by Application (2025-2031) & (US$ Million)
Figure 38. United States Fluoxetine Hydrochloride (Prozac) Sales Market Share in Value by Application (2025-2031)
Figure 39. United States Fluoxetine Hydrochloride (Prozac) Sales by Application (2025-2031) & (K Units)
Figure 40. United States Fluoxetine Hydrochloride (Prozac) Sales Market Share in Volume by Application (2025-2031)
Figure 41. United States Fluoxetine Hydrochloride (Prozac) Price by Application (2025-2031) & (US$/Unit)
Figure 42. North America Fluoxetine Hydrochloride (Prozac) Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 43. North America Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 44. U.S. Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 45. Canada Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 46. Europe Fluoxetine Hydrochloride (Prozac) Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 47. Europe Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 48. Germany Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 49. France Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 50. U.K. Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 51. Italy Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 52. Russia Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 53. Asia-Pacific Fluoxetine Hydrochloride (Prozac) Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 54. Asia-Pacific Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 55. China Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 56. Japan Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 57. South Korea Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 58. India Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 59. Australia Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 60. Taiwan Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 61. Indonesia Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 62. Thailand Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 63. Malaysia Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 64. Philippines Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 65. Latin America Fluoxetine Hydrochloride (Prozac) Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 66. Latin America Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 67. Mexico Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 68. Brazil Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 69. Argentina Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 70. Middle East & Africa Fluoxetine Hydrochloride (Prozac) Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 71. Middle East & Africa Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 72. Turkey Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 73. Saudi Arabia Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 74. U.A.E Fluoxetine Hydrochloride (Prozac) Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 75. Fluoxetine Hydrochloride (Prozac) Value Chain
Figure 76. Fluoxetine Hydrochloride (Prozac) Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.